Prevention of Thrombocytopenia in Glioblastoma Patients

NCT02227576 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
OTHER
Sponsor class

Stopped Study halted for efficacy following the results of the interim analysis provided for in the protocol on 20 patients.

Conditions

Interventions

Sponsor

University Hospital, Lille